144 related articles for article (PubMed ID: 24314141)
1. Inhibition of mouse SP2/0 myeloma cell growth by the B7-H4 protein vaccine.
Mu N; Liu N; Hao Q; Xu Y; Li J; Li W; Wu S; Zhang C; Su H
BMB Rep; 2014 Jul; 47(7):399-404. PubMed ID: 24314141
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells.
Miao G; Sun X
Biomed Pharmacother; 2021 Sep; 141():111913. PubMed ID: 34328096
[TBL] [Abstract][Full Text] [Related]
3. B7-H1 protein vaccine induces protective and therapeutic antitumor responses in SP2/0 myeloma-bearing mice.
Zhang C; Wang W; Qin X; Xu Y; Huang T; Hao Q; Li W; Wu S; Zhang Y
Oncol Rep; 2013 Nov; 30(5):2442-8. PubMed ID: 23970300
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model.
Leung J; St-Onge P; Stagg J; Suh WK
Cancer Immunol Immunother; 2017 Apr; 66(4):491-502. PubMed ID: 28074226
[TBL] [Abstract][Full Text] [Related]
5. B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation.
Wang X; Hao J; Metzger DL; Ao Z; Chen L; Ou D; Verchere CB; Mui A; Warnock GL
PLoS One; 2012; 7(1):e28232. PubMed ID: 22238573
[TBL] [Abstract][Full Text] [Related]
6. A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.
Iizuka A; Nonomura C; Ashizawa T; Kondou R; Ohshima K; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Akiyama Y
Clin Cancer Res; 2019 May; 25(9):2925-2934. PubMed ID: 30737243
[TBL] [Abstract][Full Text] [Related]
7. B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.
Rahbar R; Lin A; Ghazarian M; Yau HL; Paramathas S; Lang PA; Schildknecht A; Elford AR; Garcia-Batres C; Martin B; Berman HK; Leong WL; McCready DR; Reedijk M; Done SJ; Miller N; Youngson B; Suh WK; Mak TW; Ohashi PS
Cancer Immunol Res; 2015 Feb; 3(2):184-95. PubMed ID: 25527357
[TBL] [Abstract][Full Text] [Related]
8. Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.
Dangaj D; Lanitis E; Zhao A; Joshi S; Cheng Y; Sandaltzopoulos R; Ra HJ; Danet-Desnoyers G; Powell DJ; Scholler N
Cancer Res; 2013 Aug; 73(15):4820-9. PubMed ID: 23722540
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of monoclonal antibody against human B7-H4 molecule.
Zhang N; Fang P; Gu ZJ
Monoclon Antib Immunodiagn Immunother; 2014 Aug; 33(4):270-4. PubMed ID: 25171007
[TBL] [Abstract][Full Text] [Related]
10. Structure and cancer immunotherapy of the B7 family member B7x.
Jeon H; Vigdorovich V; Garrett-Thomson SC; Janakiram M; Ramagopal UA; Abadi YM; Lee JS; Scandiuzzi L; Ohaegbulam KC; Chinai JM; Zhao R; Yao Y; Mao Y; Sparano JA; Almo SC; Zang X
Cell Rep; 2014 Nov; 9(3):1089-98. PubMed ID: 25437562
[TBL] [Abstract][Full Text] [Related]
11. Host B7-H4 regulates antitumor T cell responses through inhibition of myeloid-derived suppressor cells in a 4T1 tumor transplantation model.
Leung J; Suh WK
J Immunol; 2013 Jun; 190(12):6651-61. PubMed ID: 23686485
[TBL] [Abstract][Full Text] [Related]
12. Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality.
Saha A; Taylor PA; Lees CJ; Panoskaltsis-Mortari A; Osborn MJ; Feser CJ; Thangavelu G; Melchinger W; Refaeli Y; Hill GR; Munn DH; Murphy WJ; Serody JS; Maillard I; Kreymborg K; van den Brink M; Dong C; Huang S; Zang X; Allison JP; Zeiser R; Blazar BR
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578305
[TBL] [Abstract][Full Text] [Related]
13. Cancer cell-associated cytoplasmic B7-H4 is induced by hypoxia through hypoxia-inducible factor-1α and promotes cancer cell proliferation.
Jeon YK; Park SG; Choi IW; Lee SW; Lee SM; Choi I
Biochem Biophys Res Commun; 2015 Apr; 459(2):277-283. PubMed ID: 25725157
[TBL] [Abstract][Full Text] [Related]
14. B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells.
Qian Y; Hong B; Shen L; Wu Z; Yao H; Zhang L
Cell Tissue Res; 2013 Jul; 353(1):139-51. PubMed ID: 23660627
[TBL] [Abstract][Full Text] [Related]
15. Blockade of both B7-H4 and CTLA-4 co-signaling pathways enhances mouse islet allograft survival.
Wang X; Hao J; Metzger DL; Mui A; Lee IF; Akhoundsadegh N; Chen CL; Ou D; Ao Z; Verchere CB; Warnock GL
Islets; 2012; 4(4):284-95. PubMed ID: 22878670
[TBL] [Abstract][Full Text] [Related]
16. B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation.
Chen X; Wang L; Wang W; Zhao L; Shan B
Cancer Sci; 2016 Jul; 107(7):944-54. PubMed ID: 27088889
[TBL] [Abstract][Full Text] [Related]
17. Unstable B7-H4 cell surface expression and T-cell redirection as a means of cancer therapy.
Iizuka A; Kondou R; Nonomura C; Ashizawa T; Ohshima K; Kusuhara M; Isaka M; Ohde Y; Yamaguchi K; Akiyama Y
Oncol Rep; 2016 Nov; 36(5):2625-2632. PubMed ID: 27632942
[TBL] [Abstract][Full Text] [Related]
18. [Preparation of anti-B7-H4 monoclonal antibody to investigate B7-H4 expression in pancreatic cancer].
Hong B; Qian Y; Yao HP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 42(5):511-6. PubMed ID: 24167131
[TBL] [Abstract][Full Text] [Related]
19. [Construction of anti-B7-H4-scFv library and screening and identification of anti-B7-H4-scFv].
Shao L; Xu C; Ji H; Mao W; Wang Y; Liu X; Zhu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Sep; 32(9):1260-6. PubMed ID: 27609584
[TBL] [Abstract][Full Text] [Related]
20. B7-H4 expression in various tumors determined using a novel developed monoclonal antibody.
Qian Y; Shen L; Cheng L; Wu Z; Yao H
Clin Exp Med; 2011 Sep; 11(3):163-70. PubMed ID: 21190056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
